Patent Assignment
Reel/Frame 061954/0230
Assignment of Assignor's Interest
Recorded: 2022-12-02
Pages: 10
Assignors
SIDDIQUI-JAIN, ADAM
Executed: 2019-12-18
FLYNN, PAUL
Executed: 2019-12-10
FUJIWARA, YUJI
Executed: 2019-12-18
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 2, 2022
From: MASUMOTO, SHUJI; TANAKA, HIROAKI; KUREBAYASHI, HIROTAKA; HASHIZUKA, TAKAHIKO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 061954/0350 →
Assignment of Assignor's Interest
Dec 2, 2022
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061954/0448 →
Merger
Dec 2, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 061954/0493 →
Change of Name
Dec 2, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 062050/0980 →
Change of Name
Dec 2, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 062051/0070 →